Determination of the Degree of Esterification in Heparin Benzylates During Synthesis of Enoxaparin, a Domestic Analog of Low-Molecular-Mass Heparin
- 作者: Frumin L.E.1, Yur’eva K.P.1, Matveev A.V.1, Vorfolomeeva E.V.1,2, Vostrov I.A.2, Zatonskii G.V.3, Prokhorov D.I.1, Zhavoronok E.S.1,2, Panov A.V.1,2, Grebenkina L.E.1, Pyatigorskaya N.V.4, Brkich G.É.4, Kedik S.A.1,2
-
隶属关系:
- M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
- Institute of Pharmaceutical Technologies
- G. F. Gause Institute of New Antibiotics
- I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
- 期: 卷 53, 编号 9 (2019)
- 页面: 852-857
- 栏目: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/246033
- DOI: https://doi.org/10.1007/s11094-019-02089-7
- ID: 246033
如何引用文章
详细
The esterification stage of low-molecular-mass heparin (enoxaparin) production by hydrolytic depolymerization of unfractionated heparin was studied and consisted of treating previously synthesized benzethonium heparinate with benzyl chloride. The content of benzyl moieties in the synthesized heparin benzylates and their degree of benzylation were determined using HPLC, PMR, and 13C NMR methods. A carboxylic-acid content of 0.13 ± 0.01 mol/g in the starting heparin was calculated from these results. A new method for estimating the degree of heparin benzylation from PMR and HPLC data was proposed. The benzyl content in the heparin benzylates increased with increasing molar excess of benzyl chloride.
作者简介
L. Frumin
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454
K. Yur’eva
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
编辑信件的主要联系方式.
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454
A. Matveev
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454
E. Vorfolomeeva
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353
I. Vostrov
Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, Skolkovo, Moscow, 121353
G. Zatonskii
G. F. Gause Institute of New Antibiotics
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 11 Bol’shaya Pirogovskaya St., Moscow, 119435
D. Prokhorov
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454
E. Zhavoronok
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353
A. Panov
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353
L. Grebenkina
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454
N. Pyatigorskaya
I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, Moscow
G. Brkich
I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, Moscow
S. Kedik
M. V. Lomonosov Institute of Fine Chemical Technologies, Russian Technological University; Institute of Pharmaceutical Technologies
Email: kristina.yureva1994@mail.ru
俄罗斯联邦, 78 Prosp. Vernadskogo, Moscow, 119454; Skolkovo, Moscow, 121353
补充文件
